Searched for
BUMBLE Q1 REVENUE
Explained: How SpaceX’s $75 billion IPO could create opportunity for Inox India shareholdersAs Elon Musk's SpaceX heads for a blockbuster IPO, investors are turning their attention to INOX India, a cryogenic technology specialist w...- MTAR Tech shares crash 9% after 280% rally in a year. What’s spooking investors today?MTAR Technologies shares fell sharply after its key client, Bloom Energy, saw its stock tumble in the US market following the suspension of...
- Explained: Why Oracle shares crashed 10% in extended trading despite earnings beatOracle shares fell sharply in after-hours trading despite beating earnings estimates, as investors reacted to aggressive AI spending plans ...
- A home that washes, cools and thinks for you: Inside LG's 'Zero Labor Home' vision for IndiaLG Electronics is building a future home powered by artificial intelligence. Intelligent appliances, connected platforms, and robots will w...
- Zee Entertainment shares rise over 3% ahead of FIFA World Cup, Rs 2,300-crore fundraising plansZee Entertainment Enterprises' shares rose after its board approved raising at least Rs 2,300 crore to fund strategic initiatives and bolst...
- Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth ra...
- SpaceX IPO a bid too far? Some opt for a proxy play with Inox IndiaInox India shares surged following reports of a massively oversubscribed SpaceX IPO, drawing investor attention to the Indian company as a ...
- Lenskart Solutions sees Rs 1,862-crore block deal; ADIA likely sellerEyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...
- DDA auction of 142 properties generates Rs 1,300 crore revenueThe Delhi Development Authority has hit a major milestone by auctioning 142 properties, bringing in a remarkable revenue of Rs 1,321 crore....
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- Afcons Infra shares soar over 9% on Rs 5,301 cr order to build world’s second-largest breakwaterAfcons Infrastructure shares surged following a significant contract win. The company will construct a 10.14-km breakwater for Vadhvan Port...
- Dixon Tech shares rise as subsidiary enters JV to manufacture optical telecom productsDixon Technologies' shares rose after its subsidiary, Dixon Electroconnect, partnered with Gemtek Technology to form a joint venture. This ...
- Bonus issue alert! Brigade Enterprises sets record date for 1:3 bonus share rewardBrigade Enterprises has fixed June 17 as the record date for its 1:3 bonus share issue after receiving shareholder approval through an e-vo...
- Zepto IPO: Aadit Palicha, Kaivalya Vohra to hold stake; Nexus Ventures biggest seller in OFSQuick commerce firm Zepto's promoters will not dilute equity in its upcoming IPO, which aims to raise Rs 8,010 crore via fresh issue and an...
- Infosys dividend alert! Last date to buy IT giant's shares to secure Rs 25/sh payoutInfosys has set June 10 as the record date to determine shareholder eligibility for its final dividend of Rs 25 per share. Since shares mus...
- Zepto Q4FY26 revenue up 75% at Rs 7,498 crore, narrows loss to Rs 1,538 croreQuick commerce firm Zepto reported a 75% revenue surge to Rs 7,498 crore in Q4 FY26, while narrowing its loss to Rs 1,539 crore. The compan...
- Groww shares gain 3% as Goldman Sachs buys stake in Rs 210-crore block dealBillionbrain Garage Ventures, parent of Groww, saw its shares rally 3% after Goldman Sachs acquired over 1.13 crore shares for Rs 210.43 cr...
- Honeywell's Quantinuum valued at $17.6 billion as shares rise in Nasdaq debutQuantinuum shares jump 13.3% in their Nasdaq debut, valuing the Honeywell-backed quantum firm at $17.6 billion. Strong investor interest re...
- UBS downgrades BHEL shares to Neutral from Buy. Check target, key reasonsUBS has downgraded BHEL to "Neutral" from "Buy", citing a more balanced risk-reward outlook after the stock's strong run, though it raised ...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
Load More
